Age as a predictive factor of disease activity after discontinuation of Disease Modifying Treatment in Multiple Sclerosis

被引：0
|
作者：
Soares, Mafalda Delgado [1 ,2 ]
Faustino, Patricia [1 ,2 ]
Sequeira, Joao [2 ]
Marques, Jose Pinto [2 ]
Sousa, Ana [2 ]
Grine, Teresa [2 ]
Mateus, Claudia [2 ]
Encarnacao, Susana [2 ]
Santos, Ana Catarina [2 ]
Gama, Anabela [2 ]
Capela, Carlos [2 ]
Ladeira, Filipa [2 ]
机构：
[1] Ctr Hosp Univ Lisboa Cent, Neurol, Dept Lisbon, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Multiple Sclerosis Ctr Integrated Responsabil, Lisbon, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1521/1363
引用
收藏
页码：970 / 971
页数：2
相关论文
共 50 条
  • [21] Is physical exercise a multiple sclerosis disease modifying treatment?
    Motl, Robert W.
    Pilutti, Lara A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (08) : 951 - 960
  • [22] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    Current Treatment Options in Neurology, 2018, 20
  • [23] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [24] Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity
    Bose, Gauruv
    Healy, Brian C.
    Saxena, Shrishti
    Saleh, Fermisk
    Glanz, Bonnie I.
    Bakshi, Rohit
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [25] Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity
    Anne-Laure Kaminsky
    Abdou Yacoubou Omorou
    Marc Soudant
    Sophie Pittion-Vouyovitch
    Maud Michaud
    René Anxionnat
    Francis Guillemin
    Marc Debouverie
    Guillaume Mathey
    Journal of Neurology, 2020, 267 : 3518 - 3527
  • [26] Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity
    Kaminsky, Anne-Laure
    Omorou, Abdou Yacoubou
    Soudant, Marc
    Pittion-Vouyovitch, Sophie
    Michaud, Maud
    Anxionnat, Rene
    Guillemin, Francis
    Debouverie, Marc
    Mathey, Guillaume
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3518 - 3527
  • [27] Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors
    Bsteh, Gabriel
    Feige, Julia
    Ehling, Rainer
    Auer, Michael
    Hegen, Harald
    Di Pauli, Franziska
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (09) : 1241 - 1248
  • [28] Discontinuation of Disease-Modifying Therapy for Patient with Relapsing-Remitting Multiple Sclerosis
    Yano, Hajime
    Gonzalez, Cindy T.
    Healy, Brian C.
    Glanz, Bonnie I.
    Weiner, Howard L.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 47 - 47
  • [29] Interrupting disease modifying treatment for pregnancy in multiple sclerosis - effect on disease activity and serum neurofilament light chain
    Yaldizli, O.
    Benkert, P.
    Bedussi, F.
    Schaedelin, S.
    Oechtering, J.
    Ceschi, A.
    Maceski, A.
    Orleth, A.
    Salmen, A.
    Granziera, C.
    Achtnichts, L.
    Pot, C.
    Du Pasquier, R.
    Lalive, P.
    Mueller, S.
    Kappos, L.
    Gobbi, C.
    Leppert, D.
    Zecca, C.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 46 - 46
  • [30] Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy's Impact on Disease Activity
    Varyte, Guoda
    Zakareviciene, Jolita
    Ramasauskaite, Diana
    Lauzikiene, Dalia
    Arlauskiene, Audrone
    MEDICINA-LITHUANIA, 2020, 56 (02):
12345